Chemical Works of Gedeon RichterRGEDF -2.91%94 5-Year Yield-on-Cost % is 35.33 as of Jul. 09, 2026, which is 121% above its 10-year median of 15.98. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.26 (Fairly Valued). The stock has 5 warning signs investors should review. Among 516 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 97.29% on this metric.
The historical rank and industry rank for Chemical Works of Gedeon Richter's 5-Year Yield-on-Cost % or its related term are showing as below:
RGEDF'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 4.39 Med: 15.98 Max: 34.37
Current: 35.33
During the past 13 years, Chemical Works of Gedeon Richter's highest Yield on Cost was 34.37. The lowest was 4.39. And the median was 15.98.
RGEDF's 5-Year Yield-on-Cost % is ranked better than 97.29% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.255
vs RGEDF: 35.33
Chemical Works of Gedeon Richter (OTCPK:RGEDF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Chemical Works of Gedeon Richter 5-Year Yield-on-Cost % Related Terms
RGEDF vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chemical Works of Gedeon Richter 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Chemical Works of Gedeon Richter's 5-Year Yield-on-Cost % falls into.
Chemical Works of Gedeon Richter 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Chemical Works of Gedeon Richter (RGEDF) has a 5-Year Yield-on-Cost % of 35.33 as of Jul. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Chemical Works of Gedeon Richter and its competitors. This is 121% above median its historical median of 15.98. Over the past decade, Chemical Works of Gedeon Richter's 5-Year Yield-on-Cost % has ranged from 4.39 to 34.37. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #14 out of 516 companies in the Drug Manufacturers industry, placing it in the top 2.7%.
Is Chemical Works of Gedeon Richter's 5-Year Yield-on-Cost % too high?
Chemical Works of Gedeon Richter's current 5-Year Yield-on-Cost % of 35.33 is 121% above median its 10-year median of 15.98. Over the past 10 years, this metric has ranged from a low of 4.39 to a high of 34.37. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.26. Chemical Works of Gedeon Richter's value of 35.33 is 1466.7% above this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #14 out of 516 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #14 out of 516 companies for 5-Year Yield-on-Cost %. This places Chemical Works of Gedeon Richter in the top 3% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.26. Chemical Works of Gedeon Richter's value of 35.33 is 1466.7% above this benchmark. Historically, Chemical Works of Gedeon Richter's own 5-Year Yield-on-Cost % has ranged from 4.39 to 34.37 over the past decade. While the company's 10-year median is 15.98 vs. the industry median of 2.26, Chemical Works of Gedeon Richter has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.26, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current 5-Year Yield-on-Cost % of 35.33 is 1466.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.26 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current 5-Year Yield-on-Cost % is 35.33, which is 121% above median its own 10-year median of 15.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Fairly Valued. The stock's GF Value™ is $35.26, compared to a current price of $37.97 — trading 7.7% above its estimated fair value. The current 5-Year Yield-on-Cost % is 35.33, which is 121% above median its 10-year median of 15.98 and 1466.7% above the Drug Manufacturers industry median of 2.26. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current 5-Year Yield-on-Cost % is 35.33 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued.
The current stock price of $37.97 is trading 7.7% above its estimated GF Value™ of $35.26.
GuruFocus considers Chemical Works of Gedeon Richter to be Fairly Valued.
Key valuation signals for RGEDF:
5-Year Yield-on-Cost %: 35.33 (121% above median its 10-year median of 15.98)
GF Value™: $35.26 vs. price of $37.97 (7.7% above fair value)
Industry Position: 1466.7% above the Drug Manufacturers median (#14 of 516)
No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chemical Works of Gedeon Richter Business Description
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score
Get the complete analysis for RGEDF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RGEDF has been successfully added to your 